Circulating innate lymphoid cells (cILCs): Unconventional lymphocytes with hidden talents

Journal of Allergy and Clinical Immunology, vol. 154, pp. 523–536

Abstract

ILC3 subset, which emerges as prognostic marker in peripheral blood for inflammatory bowel disease and leukemia.

Authors 2

1. Sabrina Bianca Bennstein corresponding Aachen Institute of Immunology Faculty of Medicine

   RWTH Aachen University · Düsseldorf University Hospital · Heinrich Heine University Düsseldorf

   Affiliation as printed

   Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; Institute of Immunology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany. Electronic address: sbennstein@ukaachen.de

   Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

   Institute of Immunology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany

2. Markus Uhrberg corresponding

   Düsseldorf University Hospital · Heinrich Heine University Düsseldorf

   Affiliation as printed

   Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. Electronic address: Markus.uhrberg@med.uni-duesseldorf.de

   Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany